Health News

Cancer Screens: Agreeing to Disagree
For years, people have been told that cancer screenings save lives. Recently, though, some organizations have said that some cancer screenings may be more harmful than helpful.
Very Low-Risk Cancer Not Black & White
Recently, men have been told to consider carefully watching instead of immediately treating prostate cancer. These recommendations reflect the fact that, in many men, prostate cancer is slow growing and may never cause a problem.
Eating Away Prostate Cancer
Once a person is diagnosed with cancer, can diet and exercise make a difference? You bet! Lifestyle is hugely important to keep cancer from progressing or returning.
Cancer Food Fight!
Scientists have found that certain foods are really good for us. These so-called “super foods” are high in antioxidants which protect the body from stress that can lead to disease.
Is it Safe to Watch Instead of Treat Prostate Cancer?
Once learning they have cancer, most people want to do whatever is necessary to get the disease out of their bodies. In some cases, though, treating the disease may be unnecessary and more harmful than helpful.
Olives, Nuts and Avocados, Oh My!
You are what you eat, right? That may be especially true with regards to diet and cancer. More and more research shows that healthier dietary choices lead to reduced cancer risks. 
Cancer Treatment: Cost Vs. Effectiveness
As technology advances, physicians and patients tend to want to use the latest treatment options. These new therapies typically come with a higher price tag. But are they better?
Hold Your Horses, Older Men!
One of the challenges of managing prostate cancer is measuring how aggressive it is. Because a man is diagnosed with prostate cancer doesn’t necessarily mean it needs to be treated.
Advanced Prostate Cancer Rx Approved
When cancer begins to spread from its original site, the bones are a common destination. Now, men with advanced prostate cancer have a new option that may help them live longer.
FDA Approves New Rx, Xofigo
The US Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.